Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Net Tangible Assets

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 (BLACR) currently reports a net tangible assets of $150M as of June 2026. That compares with $190M in the prior-year period — down 25.2% year over year. Use the charts on this page to explore Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's net tangible assets history and peer comparisons.

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's net tangible assets decreased from $190M to $150M — a 25.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 reported $150M in net tangible assets as of June 2026. That compares with $190M in the prior-year period — down 25.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028, and consider following BLACR for alerts when major investors trade the stock.